#PAGE_PARAMS# #ADS_HEAD_SCRIPTS# #MICRODATA#

Quorum Sensing Inhibition Selects for Virulence and Cooperation in


With the rising development of bacterial resistance the search for new medical treatments beyond conventional antimicrobials has become a key aim of public health research. Possible innovative strategies include the inhibition of bacterial virulence. However, consideration must be given to the evolutionary and environmental consequences of such new interventions. Virulence and cooperative social behaviour of the bacterium Pseudomonas aeruginosa rely on the quorum-sensing (QS) controlled production of extracellular products (public goods). Hence QS is an attractive target for anti-virulence interventions. During colonization, non-cooperating (and hence less virulent) P. aeruginosa QS-mutants, benefiting from public goods provided by wild type isolates, naturally increase in frequency providing a relative protection from invasive infection. We hypothesized that inhibition of QS-mediated gene expression removes this growth advantage and selection of less virulent QS-mutants, and maintains the predominance of more virulent QS-wild type bacteria. We addressed this possibility in a placebo-controlled trial investigating the anti-QS properties of azithromycin, a macrolide antibiotic devoid of bactericidal activity on P. aeruginosa, but interfering with QS, in intubated patients colonized by P. aeruginosa. In the absence of azithromycin, non-cooperating (and hence less virulent) lasR (QS)-mutants increased in frequency over time. Azithromycin significantly reduced QS-gene expression measured directly in tracheal aspirates. Concomitantly the advantage of lasR-mutants was lost and virulent wild-type isolates predominated during azithromycin treatment. We confirmed these results in vitro with fitness and invasion experiments. Azithromycin reduced growth rate of the wild-type, but not of the lasR-mutant. Furthermore, the lasR-mutant efficiently invaded wild-type populations in the absence, but not in the presence of azithromycin. These in vivo and in vitro results demonstrate that anti-virulence interventions based on QS-blockade diminish natural selection towards reduced virulence and therefore may increase the prevalence of more virulent genotypes in the Hospital environment. More generally, the impact of intervention on the evolution of virulence of pathogenic bacteria should be assessed.

Trial Registration: ClinicalTrials.gov NCT00610623


Vyšlo v časopise: Quorum Sensing Inhibition Selects for Virulence and Cooperation in. PLoS Pathog 6(5): e32767. doi:10.1371/journal.ppat.1000883
Kategorie: Research Article
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.ppat.1000883

Souhrn

With the rising development of bacterial resistance the search for new medical treatments beyond conventional antimicrobials has become a key aim of public health research. Possible innovative strategies include the inhibition of bacterial virulence. However, consideration must be given to the evolutionary and environmental consequences of such new interventions. Virulence and cooperative social behaviour of the bacterium Pseudomonas aeruginosa rely on the quorum-sensing (QS) controlled production of extracellular products (public goods). Hence QS is an attractive target for anti-virulence interventions. During colonization, non-cooperating (and hence less virulent) P. aeruginosa QS-mutants, benefiting from public goods provided by wild type isolates, naturally increase in frequency providing a relative protection from invasive infection. We hypothesized that inhibition of QS-mediated gene expression removes this growth advantage and selection of less virulent QS-mutants, and maintains the predominance of more virulent QS-wild type bacteria. We addressed this possibility in a placebo-controlled trial investigating the anti-QS properties of azithromycin, a macrolide antibiotic devoid of bactericidal activity on P. aeruginosa, but interfering with QS, in intubated patients colonized by P. aeruginosa. In the absence of azithromycin, non-cooperating (and hence less virulent) lasR (QS)-mutants increased in frequency over time. Azithromycin significantly reduced QS-gene expression measured directly in tracheal aspirates. Concomitantly the advantage of lasR-mutants was lost and virulent wild-type isolates predominated during azithromycin treatment. We confirmed these results in vitro with fitness and invasion experiments. Azithromycin reduced growth rate of the wild-type, but not of the lasR-mutant. Furthermore, the lasR-mutant efficiently invaded wild-type populations in the absence, but not in the presence of azithromycin. These in vivo and in vitro results demonstrate that anti-virulence interventions based on QS-blockade diminish natural selection towards reduced virulence and therefore may increase the prevalence of more virulent genotypes in the Hospital environment. More generally, the impact of intervention on the evolution of virulence of pathogenic bacteria should be assessed.

Trial Registration: ClinicalTrials.gov NCT00610623


Zdroje

1. HentzerM

WuH

AndersenJB

RiedelK

RasmussenTB

2003 Attenuation of Pseudomonas aeruginosa virulence by quorum sensing inhibitors. EMBO J 22 3803 3815

2. BjarnsholtT

GivskovM

2007 Quorum-sensing blockade as a strategy for enhancing host defences against bacterial pathogens. Philos Trans R Soc Lond B Biol Sci 362 1213 1222

3. Van DeldenC

IglewskiBH

1998 Cell-to-cell signaling and Pseudomonas aeruginosa infections. Emerg Infect Dis 4 551 560

4. MolinariG

GuzmanCA

PesceA

SchitoGC

1993 Inhibition of Pseudomonas aeruginosa virulence factors by subinhibitory concentrations of azithromycin and other macrolide antibiotics. J Antimicrob Chemother 31 681 688

5. TatedaK

ComteR

PechereJC

KöhlerT

YamaguchiK

2001 Azithromycin Inhibits Quorum Sensing in Pseudomonas aeruginosa. Antimicrob Agents Chemother 45 1930 1933

6. DiggleSP

GriffinAS

CampbellGS

WestSA

2007 Cooperation and conflict in quorum-sensing bacterial populations. Nature 450 411 414

7. SandozKM

MitzimbergSM

SchusterM

2007 Social cheating in Pseudomonas aeruginosa quorum sensing. Proc Natl Acad Sci U S A 104 15876 15881

8. KöhlerT

BucklingA

Van DeldenC

2009 Cooperation and virulence of clinical Pseudomonas aeruginosa populations. Proc Natl Acad Sci U S A 106 6339 6344

9. BrownSP

HochbergME

GrenfellBT

2002 Does multiple infection select for raised virulence? Trends Microbiol 10 401 405

10. WestSA

BucklingA

2003 Cooperation, virulence and siderophore production in bacterial parasites. Proc Biol Sci 270 37 44

11. BucklingA

BrockhurstMA

2008 Kin selection and the evolution of virulence. Heredity 100 484 488

12. SmithEE

BuckleyDG

WuZ

SaenphimmachakC

HoffmanLR

2006 Genetic adaptation by Pseudomonas aeruginosa to the airways of cystic fibrosis patients. Proc Natl Acad Sci U S A 103 8487 8492

13. D'ArgenioDA

WuM

HoffmanLR

KulasekaraHD

DezielE

2007 Growth phenotypes of Pseudomonas aeruginosa lasR mutants adapted to the airways of cystic fibrosis patients. Mol Microbiol 64 512 533

14. HeurlierK

DenervaudV

HaenniM

GuyL

KrishnapillaiV

2005 Quorum-sensing-negative (lasR) mutants of Pseudomonas aeruginosa avoid cell lysis and death. J Bacteriol 187 4875 4883

15. GandonS

MackinnonMJ

NeeS

ReadAF

2001 Imperfect vaccines and the evolution of pathogen virulence. Nature 414 751 756

16. NalcaY

JanschL

BredenbruchF

GeffersR

BuerJ

2006 Quorum-sensing antagonistic activities of azithromycin in Pseudomonas aeruginosa PAO1: a global approach. Antimicrob Agents Chemother 50 1680 1688

17. PearsonJP

PesciEC

IglewskiBH

1997 Roles of Pseudomonas aeruginosa las and rhl quorum-sensing systems in control of elastase and rhamnolipid biosynthesis genes. J Bacteriol 179 5756 5767

18. DuanK

DammelC

SteinJ

RabinH

SuretteMG

2003 Modulation of Pseudomonas aeruginosa gene expression by host microflora through interspecies communication. Mol Microbiol 50 1477 1491

19. DanesiR

LupettiA

BarbaraC

GhelardiE

ChellaA

2003 Comparative distribution of azithromycin in lung tissue of patients given oral daily doses of 500 and 1000 mg. J Antimicrob Chemother 51 939 945

20. Le BerreR

NguyenS

NowakE

KipnisE

PierreM

2008 Quorum-sensing activity and related virulence factor expression in clinically pathogenic isolates of Pseudomonas aeruginosa. Clin Microbiol Infect 14 337 343

21. SmithRS

IglewskiBH

2003 P. aeruginosa quorum-sensing systems and virulence. Curr Opin Microbiol 6 56 60

22. RumbaughKP

DiggleSP

WattersCM

Ross-GillespieA

GriffinAS

2009 Quorum sensing and the social evolution of bacterial virulence. Curr Biol 19 341 345

23. HarrisonEF

BrowningL

VosM

BucklingA

2006 Cooperation and virulence in acute Pseudomonas aeruginosa infections. BMC Biology 4 21

24. BrownSP

JohnstoneRA

2001 Cooperation in the dark: signalling and collective action in quorum-sensing bacteria. Proc Biol Sci 268 961 965

25. KöhlerT

Kocjancic-CurtyL

BarjaF

Van DeldenC

PechèreJC

2000 Swarming of Pseudomonas aeruginosa is dependent on cell-to-cell signaling and requires flagella and pili. J Bacteriol 182 5990 5996

26. LenskiRE

RoseMR

SimpsonSC

TadlerSC

1991 Long term experimental evolution in Escherichia coli. 1. Adaptation and divergence during 2000 generations. Am Nat 138 1315 1341

Štítky
Hygiena a epidemiológia Infekčné lekárstvo Laboratórium

Článok vyšiel v časopise

PLOS Pathogens


2010 Číslo 5
Najčítanejšie tento týždeň
Najčítanejšie v tomto čísle
Kurzy

Zvýšte si kvalifikáciu online z pohodlia domova

Získaná hemofilie - Povědomí o nemoci a její diagnostika
nový kurz

Eozinofilní granulomatóza s polyangiitidou
Autori: doc. MUDr. Martina Doubková, Ph.D.

Všetky kurzy
Prihlásenie
Zabudnuté heslo

Zadajte e-mailovú adresu, s ktorou ste vytvárali účet. Budú Vám na ňu zasielané informácie k nastaveniu nového hesla.

Prihlásenie

Nemáte účet?  Registrujte sa

#ADS_BOTTOM_SCRIPTS#